dapsone has been researched along with imiquimod in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Al-Mutairi, N; Alshiltawy, M; Darwish, I; Eassa, BI; El Khalawany, M; Gomaa, S; Joshi, A; Manchanda, Y; Rijhwani, M | 1 |
| Alaibac, M; Ferranti, M; Tadiotto Cicogna, G; Vaccari, D | 1 |
3 other study(ies) available for dapsone and imiquimod
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Tropical medicine rounds: Treatment of Old World cutaneous leishmaniasis with dapsone, itraconazole, cryotherapy, and imiquimod, alone and in combination.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Ambulatory Care Facilities; Aminoquinolines; Anti-Infective Agents; Antiprotozoal Agents; Combined Modality Therapy; Cryotherapy; Dapsone; Drug Therapy, Combination; Female; Humans; Imiquimod; Itraconazole; Kuwait; Leishmaniasis, Cutaneous; Male; Middle Aged; Treatment Outcome; Young Adult | 2009 |
Topical imiquimod-induced linear IgA bullous dermatosis.
Topics: Administration, Cutaneous; Aged; Antineoplastic Agents; Carcinoma, Basal Cell; Dapsone; Facial Neoplasms; Female; Humans; Imiquimod; Linear IgA Bullous Dermatosis | 2019 |